<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Lexicon Pharmaceuticals</title><link>https://investorshangout.com/Lexicon-Pharmaceuticals-LXRX-54683/</link><description><![CDATA[Lexicon Pharmaceuticals (LXRX)]]></description><language>en-us</language><pubDate>Mon, 02 Nov 2026 10:18:55 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Lexicon-Pharmaceuticals-LXRX-54683/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals to Participate in the Bank of America Securities Health</title><link>https://investorshangout.com/post/view?id=6692424</link><guid>https://investorshangout.com/post/view?id=6692424</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 09 May 2024 20:00:51 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals to Host 2024 Investor Day </title><link>https://investorshangout.com/post/view?id=6686030</link><guid>https://investorshangout.com/post/view?id=6686030</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 18 Apr 2024 18:20:48 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare C</title><link>https://investorshangout.com/post/view?id=6656358</link><guid>https://investorshangout.com/post/view?id=6656358</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 21 Dec 2023 21:25:58 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - INPEFA (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Fai</title><link>https://investorshangout.com/post/view?id=6643247</link><guid>https://investorshangout.com/post/view?id=6643247</guid><description><![CDATA[whytestocks
]]></description><pubDate>Sun, 12 Nov 2023 19:15:45 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - New Data Relating to Sotagliflozin to be Presented at the American Society of N</title><link>https://investorshangout.com/post/view?id=6638889</link><guid>https://investorshangout.com/post/view?id=6638889</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 30 Oct 2023 20:05:50 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59</title><link>https://investorshangout.com/post/view?id=6622565</link><guid>https://investorshangout.com/post/view?id=6622565</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 26 Sep 2023 15:25:48 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Elects Diane E. Sullivan to Board of Directors </title><link>https://investorshangout.com/post/view?id=6601899</link><guid>https://investorshangout.com/post/view?id=6601899</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 28 Jul 2023 18:00:50 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Announces FDA Approval of INPEFA(TM) (sotagliflozin) for Treatment of H</title><link>https://investorshangout.com/post/view?id=6579641</link><guid>https://investorshangout.com/post/view?id=6579641</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 26 May 2023 20:15:48 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia </title><link>https://investorshangout.com/post/view?id=6564815</link><guid>https://investorshangout.com/post/view?id=6564815</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 21 Apr 2023 16:35:49 GMT</pubDate></item><item><title>znewcar1: $LXRX 22% v1,7M c2.68 f188,725M H2.85 ML2.13=RL</title><link>https://investorshangout.com/post/view?id=6544401</link><guid>https://investorshangout.com/post/view?id=6544401</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 03 Mar 2023 22:04:33 GMT</pubDate></item><item><title>znewcar1: $LXRX RL2.13 HOD2.72&gt; V&gt;800K</title><link>https://investorshangout.com/post/view?id=6544206</link><guid>https://investorshangout.com/post/view?id=6544206</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 03 Mar 2023 17:29:12 GMT</pubDate></item><item><title>BooDog: $LXRX looks to be on the move</title><link>https://investorshangout.com/post/view?id=6434531</link><guid>https://investorshangout.com/post/view?id=6434531</guid><description><![CDATA[BooDog
]]></description><pubDate>Fri, 08 Jul 2022 10:50:40 GMT</pubDate></item><item><title>znewcar1: LXRX 41% v27,5M c2.75 f149,6M H2.97</title><link>https://investorshangout.com/post/view?id=6433161</link><guid>https://investorshangout.com/post/view?id=6433161</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 05 Jul 2022 20:08:40 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Welcomes New Guidelines for the Management of Heart Failure </title><link>https://investorshangout.com/post/view?id=6376812</link><guid>https://investorshangout.com/post/view?id=6376812</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 04 Apr 2022 16:00:56 GMT</pubDate></item><item><title>BooDog: Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan H</title><link>https://investorshangout.com/post/view?id=6320604</link><guid>https://investorshangout.com/post/view?id=6320604</guid><description><![CDATA[BooDog
]]></description><pubDate>Thu, 13 Jan 2022 14:07:15 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon&#039;s Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing</title><link>https://investorshangout.com/post/view?id=6221971</link><guid>https://investorshangout.com/post/view?id=6221971</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 23 Aug 2021 14:55:52 GMT</pubDate></item><item><title>znewcar1: LXRX 18% v10,2M c5.72 f144M afternoon pop push to HOD6.06 from 4.9</title><link>https://investorshangout.com/post/view?id=6169123</link><guid>https://investorshangout.com/post/view?id=6169123</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 25 Jun 2021 22:51:06 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Associatio</title><link>https://investorshangout.com/post/view?id=6168866</link><guid>https://investorshangout.com/post/view?id=6168866</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 25 Jun 2021 17:25:50 GMT</pubDate></item><item><title>znewcar1: LXRX 105% v160M c8.05 f141M H9.7 nice run 3 stepR@5,7&amp;9 </title><link>https://investorshangout.com/post/view?id=6019497</link><guid>https://investorshangout.com/post/view?id=6019497</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 14 Jan 2021 21:06:15 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - 5 Hot Penny Stocks To Watch This Week </title><link>https://investorshangout.com/post/view?id=5993838</link><guid>https://investorshangout.com/post/view?id=5993838</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 17 Dec 2020 21:05:48 GMT</pubDate></item><item><title>BooDog: BOOM!!!! Fast track granted. https://finance.yahoo.com/news/lexicon-pharmaceuticals-receives-fast</title><link>https://investorshangout.com/post/view?id=5987433</link><guid>https://investorshangout.com/post/view?id=5987433</guid><description><![CDATA[BooDog
]]></description><pubDate>Fri, 11 Dec 2020 12:56:40 GMT</pubDate></item><item><title>znewcar1: LXRX 78% v203M c3.08 f117M H4.04 S3 gap + go</title><link>https://investorshangout.com/post/view?id=5984314</link><guid>https://investorshangout.com/post/view?id=5984314</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 08 Dec 2020 21:10:55 GMT</pubDate></item><item><title>znewcar1: LXRX 40% v102M c1.81 f117M H2.38 S1.71</title><link>https://investorshangout.com/post/view?id=5965618</link><guid>https://investorshangout.com/post/view?id=5965618</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 17 Nov 2020 21:17:27 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-</title><link>https://investorshangout.com/post/view?id=5884687</link><guid>https://investorshangout.com/post/view?id=5884687</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 04 Sep 2020 16:05:47 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provi</title><link>https://investorshangout.com/post/view?id=5844146</link><guid>https://investorshangout.com/post/view?id=5844146</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 30 Jul 2020 15:40:46 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagl</title><link>https://investorshangout.com/post/view?id=5833621</link><guid>https://investorshangout.com/post/view?id=5833621</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 21 Jul 2020 14:50:48 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Poster Presentations at the Virtual Cholangio</title><link>https://investorshangout.com/post/view?id=5831855</link><guid>https://investorshangout.com/post/view?id=5831855</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 20 Jul 2020 12:20:49 GMT</pubDate></item><item><title>whytestocks: $LXRX good read </title><link>https://investorshangout.com/post/view?id=5626924</link><guid>https://investorshangout.com/post/view?id=5626924</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 24 Dec 2019 14:10:46 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211 </title><link>https://investorshangout.com/post/view?id=5610245</link><guid>https://investorshangout.com/post/view?id=5610245</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 05 Dec 2019 13:00:45 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Is Lexicon Pharmaceuticals a Buy? </title><link>https://investorshangout.com/post/view?id=5604285</link><guid>https://investorshangout.com/post/view?id=5604285</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 27 Nov 2019 16:45:42 GMT</pubDate></item><item><title>znewcar1: LXRX 29% v15,9M c3.80 f106M H 3.89 bull run day got S@3.4 Looks like gap if filled.</title><link>https://investorshangout.com/post/view?id=5542782</link><guid>https://investorshangout.com/post/view?id=5542782</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 18 Sep 2019 21:24:15 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Here&#039;s Why Lexicon Pharmaceuticals Is Soaring This Week </title><link>https://investorshangout.com/post/view?id=5537611</link><guid>https://investorshangout.com/post/view?id=5537611</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 12 Sep 2019 19:50:42 GMT</pubDate></item><item><title>znewcar1: LXRX 27% v14,5M c2.20 f106M big gap up ramped up to 2.71 then fell back S@ 2.12 </title><link>https://investorshangout.com/post/view?id=5536535</link><guid>https://investorshangout.com/post/view?id=5536535</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 11 Sep 2019 21:03:35 GMT</pubDate></item><item><title>znewcar1: LXRX 21% v3,1M c1.72 f106M </title><link>https://investorshangout.com/post/view?id=5535214</link><guid>https://investorshangout.com/post/view?id=5535214</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 10 Sep 2019 20:32:32 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With S</title><link>https://investorshangout.com/post/view?id=5535166</link><guid>https://investorshangout.com/post/view?id=5535166</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 10 Sep 2019 20:05:47 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class? </title><link>https://investorshangout.com/post/view?id=5530787</link><guid>https://investorshangout.com/post/view?id=5530787</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 05 Sep 2019 18:05:46 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Active Stock among hottest- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) </title><link>https://investorshangout.com/post/view?id=5517093</link><guid>https://investorshangout.com/post/view?id=5517093</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 21 Aug 2019 15:50:40 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Zynquista(TM) now Approved in the European Union for Treatment of Adults With T</title><link>https://investorshangout.com/post/view?id=5423478</link><guid>https://investorshangout.com/post/view?id=5423478</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 26 Apr 2019 20:05:40 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - LEAD PLAINTIFF DEADLINE ALERT: Faruqi &amp; Faruqi, LLP Encourages Investors Who Su</title><link>https://investorshangout.com/post/view?id=5396816</link><guid>https://investorshangout.com/post/view?id=5396816</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 29 Mar 2019 17:25:40 GMT</pubDate></item><item><title>whytestocks: $LXRX News Article - Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Res</title><link>https://investorshangout.com/post/view?id=5377839</link><guid>https://investorshangout.com/post/view?id=5377839</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 13 Mar 2019 16:05:40 GMT</pubDate></item><item><title>znewcar1: 28.01% v3,289,620 c6.81 f105,925,402 H7.07 gap up and BO 6 &amp; 7</title><link>https://investorshangout.com/post/view?id=5366167</link><guid>https://investorshangout.com/post/view?id=5366167</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 01 Mar 2019 21:26:47 GMT</pubDate></item><item><title>znewcar1: 11% 2.1M C11.60 above all mda</title><link>https://investorshangout.com/post/view?id=5069176</link><guid>https://investorshangout.com/post/view?id=5069176</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 31 May 2018 20:22:15 GMT</pubDate></item><item><title>Jake13: LXRX Stock year to date has changed +28.57% percent. +30.00% in the last 30 days. $LXRX Lexicon P</title><link>https://investorshangout.com/post/view?id=2779510</link><guid>https://investorshangout.com/post/view?id=2779510</guid><description><![CDATA[Jake13
]]></description><pubDate>Tue, 10 Mar 2015 06:26:50 GMT</pubDate></item><item><title>chartguy89: LXRX 1.17 Lexicon Pharmaceuticals Stock Charts $LXRX Last Updated: 03/09/15 Last price: 1.17 </title><link>https://investorshangout.com/post/view?id=2779426</link><guid>https://investorshangout.com/post/view?id=2779426</guid><description><![CDATA[chartguy89
]]></description><pubDate>Tue, 10 Mar 2015 06:06:15 GMT</pubDate></item><item><title>chartguy89: LXRX 1.12 Lexicon Pharmaceuticals Stock Charts $LXRX Last Updated: 03/05/15 Last price: 1.12 </title><link>https://investorshangout.com/post/view?id=2767771</link><guid>https://investorshangout.com/post/view?id=2767771</guid><description><![CDATA[chartguy89
]]></description><pubDate>Fri, 06 Mar 2015 08:21:15 GMT</pubDate></item><item><title>Jake13: LXRX Stock year to date has changed +15.38% percent. +17.98% in the last 30 days. $LXRX Lexicon P</title><link>https://investorshangout.com/post/view?id=2760302</link><guid>https://investorshangout.com/post/view?id=2760302</guid><description><![CDATA[Jake13
]]></description><pubDate>Thu, 05 Mar 2015 07:31:09 GMT</pubDate></item><item><title>chartguy89: LXRX 1.05 Lexicon Pharmaceuticals Stock Charts $LXRX Last Updated: 03/04/15 Last price: 1.05 </title><link>https://investorshangout.com/post/view?id=2760226</link><guid>https://investorshangout.com/post/view?id=2760226</guid><description><![CDATA[chartguy89
]]></description><pubDate>Thu, 05 Mar 2015 07:14:23 GMT</pubDate></item><item><title>Jake13: LXRX Stock year to date has changed +7.69% percent. +7.69% in the last 30 days. $LXRX Lexicon Pha</title><link>https://investorshangout.com/post/view?id=2755032</link><guid>https://investorshangout.com/post/view?id=2755032</guid><description><![CDATA[Jake13
]]></description><pubDate>Wed, 04 Mar 2015 08:25:41 GMT</pubDate></item><item><title>chartguy89: LXRX 0.98 Lexicon Pharmaceuticals Stock Charts $LXRX Last Updated: 03/03/15 Last price: 0.98 </title><link>https://investorshangout.com/post/view?id=2754936</link><guid>https://investorshangout.com/post/view?id=2754936</guid><description><![CDATA[chartguy89
]]></description><pubDate>Wed, 04 Mar 2015 08:01:44 GMT</pubDate></item><item><title>chartguy89: LXRX 0.95 Lexicon Pharmaceuticals Stock Charts $LXRX Last Updated: 03/02/15 Last price: 0.95 </title><link>https://investorshangout.com/post/view?id=2749702</link><guid>https://investorshangout.com/post/view?id=2749702</guid><description><![CDATA[chartguy89
]]></description><pubDate>Tue, 03 Mar 2015 10:55:30 GMT</pubDate></item></channel></rss>